LEONARD BELL

CIK 1231949 · CEO · last filed 2017-03-01

LEONARD BELL is a CEO who has filed 116 SEC Form 4 insider transactions across 0 companies. 155 SEC filings were submitted jointly with ALEXION PHARMACEUTICALS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

0

Total Filings

116

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

C/O ALEXION PHARMACEUTICALS INC
352 KNOTTER DRIVE
CHESHIRE, CT 06410

Related Filers

ALEXION PHARMACEUTICALS, INC. — 155 joint filings, latest 2017-03-01

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
No companies on record.

Recent Filings

116 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $
2017-03-01	—	Sell (S)	−3,978	-$524.9K
2017-02-10	—	Sell (S)	−246	-$31.2K
2017-02-08	—	Sell (S)	−8,725	-$1.10M
2017-01-13	—	Mixed	—	-$12.2K
2017-01-09	—	Mixed	−1,002	-$4.65M
2016-11-07	—	Mixed	−668	-$4.40M
2016-11-02	—	Mixed	−334	-$191.3K
2016-08-10	—	Sell (S)	−1,010	-$138.5K
2016-05-13	—	Grant (A)	+835	$0
2016-03-01	—	Sell (S)	−3,995	-$555.0K

Showing 1–10 of 116

Page 1 of 12 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.